Position in PMVP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$626,358
+$39,390 QoQ
Shares Held
467,432
-1.3% QoQ
Ownership
0.874%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#14
of 64 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PMVP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Aldebaran Capital, LLC holds $7,545,514 across 6 Biotechnology names. PMVP ranks #3 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACRS |
Aclaris Therapeutics, Inc.
|
936,731 | $4,955,306 | |
| 2 | TECX |
Tectonic Therapeutic, Inc.
|
36,797 | $1,265,080 | |
| 3 | PMVP |
PMV Pharmaceuticals, Inc.
This page
|
467,432 | $626,358 | |
| 4 | AVIR |
Atea Pharmaceuticals, Inc.
|
88,180 | $410,037 | |
| 5 | OKUR |
OnKure Therapeutics, Inc.
|
39,869 | $181,802 | |
| 6 | IMA |
ImageneBio, Inc.
|
18,124 | $106,931 |
All Filings in PMVP
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $626,358 | 467,432 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $586,968 | 473,362 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $597,485 | 477,988 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $705,779 | 504,128 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $546,035 | 515,128 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $570,672 | 523,553 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $758,306 | 502,190 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $652,995 | 438,252 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $569,013 | 351,243 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||